OVERVIEW

The symposium will use case-based discussions, promote the understanding of recent technologies for the treatment of mitral tricuspid or aortic valve works.

The program will highlight patients’ characteristics that qualify them to benefit from these technologies.

TARGET AUDIENCE

The target audience includes physicians, physician assistants, nurse practitioners, registered nurses, and other medical care providers who are interested in this medical care.

LEARNING OBJECTIVES

At the conclusion of this symposium, participants should be able to:

• Discuss the mechanisms by which mitral clip and TAVR valves improve maladies of mitral, tricuspid and aortic valves
• Discuss percutaneous treatment of tricuspid valve disease
• Participants will learn how to recognize the treatment of mitral, tricuspid, congenital and aortic valve disease benefiting patients with the new technology

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Texas Heart Institute and Baylor College of Medicine. The Texas Heart Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Texas Heart Institute designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 For more information please visit the official event page.